CAS RN: 359004-20-9
Carbamic acid, (3-oxo-4-isoxazolidinyl)-, 1,1-dimethylethyl ester (9CI)
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 359004-20-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
359004-20-9 / tert-butyl N-(3-oxo-1,2-oxazolidin-4-yl)carbamate
Standard CAS: 359004-20-9
Multi CAS: No
Basic Information
copy
CAS
359004-20-9 copy
Multi CAS
No copy
Molecular Formula
C8H14N2O4 copy
Molecular Weight
202.210000 copy
Exact Mass
202.095357 copy
InChI
InChI=1S/C8H14N2O4/c1-8(2,3)14-7(12)9-5-4-13-10-6(5)11/h5H,4H2,1-3H3,(H,9,12)(H,10,11) copy
InChIKey
VNNOMGVHZFZWLD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Fraction Csp3
0.75 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
47.25 copy
TPSA
76.66 copy
LogP / Solubility
WLOGP
-0.06 copy
MLOGP
-0.05 copy
XLogP3
0.1 copy
Consensus LogP
0.0000 copy
Log S (ESOL)
-0.99 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-1.18 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.05 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy